Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium oxalate crystal formation is a pathophysiological process where calcium and oxalate ions precipitate to form crystals, primarily in the urinary tract, leading to kidney stone formation and associated renal cell injury. The process is influenced by factors such as supersaturation, pH, energy input, and the presence of inhibitors or promotors of crystallization. In nature, calcium oxalate crystals serve physiological roles in plants and lichens, such as calcium regulation and protection, but in humans this process is predominantly associated with disease states. Therapeutic research is focused on designing molecules that inhibit crystal nucleation, growth, or aggregation to prevent kidney stone disease.
Inhibition by surface modifiers (e.g., polyphosphates act by binding to crystal faces, occlusion within crystal lattice, and kinetic inhibition of growth and aggregation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium oxalate crystal formation.